Eden Research (LON:EDEN) Trading Down 3.3% – What’s Next?

Shares of Eden Research plc (LON:EDEN) fell 3.3% during mid-day trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares were traded during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 3.3 %

The company has a market cap of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The company has a fifty day moving average of GBX 3.88 and a 200 day moving average of GBX 3.95.

Insiders Place Their Bets

In related news, insider Alexander John Abrey acquired 540,540 shares of Eden Research stock in a transaction dated Tuesday, January 28th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek bought 256,000 shares of the stock in a transaction that occurred on Thursday, February 6th. The shares were bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.